Tadjoung Waffo Armel franklin

Mr. Tadjoung Waffo Armel franklin

Technische Universität Berlin
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
TFTadjoung Waffo Armel franklin
Tadjoung Waffo Armel franklin
CYC. Yesildag
C. Yesildag
GCGiorgio Caserta
Giorgio Caserta
SKS. Katz
S. Katz
IZI. Zebger
I. Zebger
ZAZ. Altintas
Z. Altintas

11 December 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
GCGiorgio Caserta
Giorgio Caserta
VPVladimir Pelmenschikov
Vladimir Pelmenschikov
CLChristian Lorent
Christian Lorent
TFTadjoung Waffo Armel franklin
Tadjoung Waffo Armel franklin
SKSagie Katz
Sagie Katz
IZIngo Zebger
Ingo Zebger
Active site vibrations of a [NiFe]-hydrogenase catalytic subunit are selectively probed by IR and NRV spectroscopy in two NiIIFeII and NiIIIFeII resting states, contributing in combination with DFT modeling to rationalized structural candidates.

27 March 2021 in Biosensors
Verified
Journal Article
Open access
PDF file
TFTadjoung Waffo Armel franklin
Tadjoung Waffo Armel franklin
BMBiljana Mitrova
Biljana Mitrova
KTKim Tiedemann
Kim Tiedemann
CIChantal Iobbi-Nivol
Chantal Iobbi-Nivol
SLSilke Leimkühler
Silke Leimkühler
Ulla WollenbergerUlla Wollenberger
Ulla Wollenberger
An amperometric trimethylamine N-oxide (TMAO) biosensor is reported, where TMAO reductase (TorA) and glucose oxidase (GOD) and catalase (Cat) were immobilized on the electrode surface, enabling measurements of mediated enzymatic TMAO reduction at low potential under ambient air conditions. The oxygen anti-interference membrane composed of GOD, Cat and polyvinyl alcohol (PVA) hydrogel, together with glucose concentration, was optimized until the O2 reduction current of a Clark-type electrode was completely suppressed for at least 3 h. For the preparation of the TMAO biosensor, Escherichia coli TorA was purified under anaerobic conditions and immobilized on the surface of a carbon electrode and covered by the optimized O2 scavenging membrane. The TMAO sensor operates at a potential of −0.8 V vs. Ag/AgCl (1 M KCl), where the reduction of methylviologen (MV) is recorded. The sensor signal depends linearly on TMAO concentrations between 2 µM and 15 mM, with a sensitivity of 2.75 ± 1.7 µA/mM. The developed biosensor is characterized by a response time of about 33 s and an operational stability over 3 weeks. Furthermore, measurements of TMAO concentration were performed in 10% human serum, where the lowest detectable concentration is of 10 µM TMAO.

22 November 2018 in ChemElectroChem
Verified
Journal Article
Closed access
PDF file
BMBiljana Mitrova
Biljana Mitrova
TFTadjoung Waffo Armel franklin
Tadjoung Waffo Armel franklin
PKPaul Kaufmann
Paul Kaufmann
CIChantal Iobbi‐Nivol
Chantal Iobbi‐Nivol
SLSilke Leimkühler
Silke Leimkühler
Ulla WollenbergerUlla Wollenberger
Ulla Wollenberger

3 June 2021 in Chemosensors
Verified
Journal Article
Open access
PDF file
XZXiaorong Zhang
Xiaorong Zhang
GCGiorgio Caserta
Giorgio Caserta
Aysu YarmanAysu Yarman
Aysu Yarman
ESEszter Supala
Eszter Supala
TFTadjoung Waffo Armel franklin
Tadjoung Waffo Armel franklin
Frieder W. SchellerFrieder W. Scheller
Frieder W. Scheller
The epitope imprinting approach applies exposed peptides as templates to synthesize Molecularly Imprinted Polymers (MIPs) for the recognition of the parent protein. While generally the template protein binding to such MIPs is considered to occur via the epitope-shaped cavities, unspecific interactions of the analyte with non-imprinted polymer as well as the detection method used may add to the complexity and interpretation of the target rebinding. To get new insights on the effects governing the rebinding of analytes, we electrosynthesized two epitope-imprinted polymers using the N-terminal pentapeptide VHLTP-amide of human hemoglobin (HbA) as the template. MIPs were prepared either by single-step electrosynthesis of scopoletin/pentapeptide mixtures or electropolymerization was performed after chemisorption of the cysteine extended VHLTP peptide. Rebinding of the target peptide and the parent HbA protein to the MIP nanofilms was quantified by square wave voltammetry using a redox probe gating, surface enhanced infrared absorption spectroscopy, and atomic force microscopy. While binding of the pentapeptide shows large influence of the amino acid sequence, all three methods revealed strong non-specific binding of HbA to both polyscopoletin-based MIPs with even higher affinities than the target peptides.

22 October 2024 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
AYAysu Yarman
Aysu Yarman
TFTadjoung Waffo Armel franklin
Tadjoung Waffo Armel franklin
SKSagie Katz
Sagie Katz
CBCornelius Bernitzky
Cornelius Bernitzky
NKNorbert Kovács
Norbert Kovács
IZIngo Zebger
Ingo Zebger
Molecularly imprinted polymers (MIPs) are artificial receptors equipped with selective recognition sites for target molecules. One of the most promising strategies for protein MIPs relies on the exploitation of short surface‐exposed protein fragments, termed epitopes, as templates to imprint binding sites in a polymer scaffold for a desired protein. However, the lack of high‐resolution structural data of flexible surface‐exposed regions challenges the selection of suitable epitopes. Here, we addressed this drawback by developing a polyscopoletin‐based MIP that recognizes recombinant proteins via imprinting of the widely used Strep‐tag II affinity peptide (Strep‐MIP). Electrochemistry, surface‐sensitive IR spectroscopy, and molecular dynamics simulations were employed to ensure an utmost control of the Strep‐MIP electrosynthesis. The functionality of this novel platform was verified with two Strep‐tagged enzymes: an O2‐tolerant [NiFe]‐hydrogenase, and an alkaline phosphatase. The enzymes preserved their biocatalytic activities after multiple utilization confirming the efficiency of Strep‐MIP as a general biocompatible platform to confine recombinant proteins for exploitation in biotechnology.